Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early rhBNP in STEMI Patients After PCI
NCT04033861Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Jun 2019
- Primary completion
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of nesiritide in ST-segment elevation myocardial infarction (STEMI), sponsored by Renji Hospital. Status: unknown.
02
Drugs
nesiritide
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04033861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04033861.